[Retracted] Changes and Prognostic Value of lncRNA CASC9 in Patients with Advanced Colon Cancer after Chemotherapy

Table 2

Multivariate analysis.

Factors	Single factors of PFS			Single factor of OS
	value	HR value	95% CI	value	HR value	95 CI%
Age (≥60 years vs. <60 years)	0.296	0.742	0.424–1.298	0.959	1.014	0.589–1.747
Sex (male vs. female)	0.867	0.952	0.538–1.686	0.803	0.924	0.497–1.719
Clinical staging (III vs. IV)	0.004	2.615	1.367–5.001	0.002	2.555	1.393–4.687
Number of lymph node metastases (≥12 vs. <12)	0.001	0.331	0.172–0.638	0.008	0.456	0.256–0.812
Location of lesion (left colon vs. right colon)	0.207	1.424	0.822–2.466	0.459	1.23	0.711–2.127
lncRNA CASC9 (≥2.38 vs. <2.38)	<0.001	3.716	1.879–7.352	0.513	1.25	0.64–2.441